247 related articles for article (PubMed ID: 19159453)
1. Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.
Irish A; Dogra G; Mori T; Beller E; Heritier S; Hawley C; Kerr P; Robertson A; Rosman J; Paul-Brent PA; Starfield M; Polkinghorne K; Cass A
BMC Nephrol; 2009 Jan; 10():1. PubMed ID: 19159453
[TBL] [Abstract][Full Text] [Related]
2. The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.
Viecelli AK; Pascoe E; Polkinghorne KR; Hawley C; Paul-Brent PA; Badve SV; Cass A; Heritier S; Kerr PG; Mori TA; Robertson A; Seong HL; Irish AB;
BMC Nephrol; 2015 Jun; 16():89. PubMed ID: 26116581
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.
Viecelli AK; Pascoe EM; Polkinghorne KR; Hawley CM; Paul-Brent PA; Badve SV; Cass A; Johnson DW; Kerr PG; Mori TA; Scaria A; Hooi SL; Ong ML; Irish AB;
Nephrology (Carlton); 2016 Mar; 21(3):217-28. PubMed ID: 26205903
[TBL] [Abstract][Full Text] [Related]
4. Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.
Viecelli AK; Polkinghorne KR; Pascoe EM; Paul-Brent PA; Hawley CM; Badve SV; Cass A; Hooi LS; Kerr PG; Mori TA; Ong LM; Voss D; Johnson DW; Irish AB;
PLoS One; 2019; 14(3):e0213274. PubMed ID: 30913208
[TBL] [Abstract][Full Text] [Related]
5. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.
Mohamed I; Kamarizan MFA; Da Silva A
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD002786. PubMed ID: 34298589
[TBL] [Abstract][Full Text] [Related]
6. Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial.
Irish AB; Viecelli AK; Hawley CM; Hooi LS; Pascoe EM; Paul-Brent PA; Badve SV; Mori TA; Cass A; Kerr PG; Voss D; Ong LM; Polkinghorne KR;
JAMA Intern Med; 2017 Feb; 177(2):184-193. PubMed ID: 28055065
[TBL] [Abstract][Full Text] [Related]
7. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.
Tanner NC; Da Silva A
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002786. PubMed ID: 26184395
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease.
Tam KW; Wu MY; Siddiqui FJ; Chan ES; Zhu Y; Jafar TH
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011353. PubMed ID: 30480758
[TBL] [Abstract][Full Text] [Related]
9. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.
Osborn G; Escofet X; Da Silva A
Cochrane Database Syst Rev; 2008 Oct; (4):CD002786. PubMed ID: 18843633
[TBL] [Abstract][Full Text] [Related]
10. Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study.
Hasegawa T; Elder SJ; Bragg-Gresham JL; Pisoni RL; Yamazaki S; Akizawa T; Jadoul M; Hugh RC; Port FK; Fukuhara S
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1373-8. PubMed ID: 18596119
[TBL] [Abstract][Full Text] [Related]
11. Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
Fan PY; Lee CC; Liu SH; Li IJ; Weng CH; Tu KH; Hsieh MY; Kuo CF; Chang TY; Tian YC; Yang CW; Wu HH
J Thromb Haemost; 2019 Jan; 17(1):77-87. PubMed ID: 30472783
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of the kidney disease outcomes quality initiative guidelines for preemptive vascular access in an academic setting.
Kimball TA; Barz K; Dimond KR; Edwards JM; Nehler MR
J Vasc Surg; 2011 Sep; 54(3):760-5; discussion 765-6. PubMed ID: 21703804
[TBL] [Abstract][Full Text] [Related]
13. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.
Da Silva AF; Escofet X; Rutherford PA
Cochrane Database Syst Rev; 2003; (2):CD002786. PubMed ID: 12804437
[TBL] [Abstract][Full Text] [Related]
14. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.
Dember LM; Beck GJ; Allon M; Delmez JA; Dixon BS; Greenberg A; Himmelfarb J; Vazquez MA; Gassman JJ; Greene T; Radeva MK; Braden GL; Ikizler TA; Rocco MV; Davidson IJ; Kaufman JS; Meyers CM; Kusek JW; Feldman HI;
JAMA; 2008 May; 299(18):2164-71. PubMed ID: 18477783
[TBL] [Abstract][Full Text] [Related]
15. Medical Adjuvant Treatment to Improve the Patency of Arteriovenous Fistulae and Grafts: A Systematic Review and Meta-analysis.
Tanner NC; da Silva AF
Eur J Vasc Endovasc Surg; 2016 Aug; 52(2):243-52. PubMed ID: 27289558
[TBL] [Abstract][Full Text] [Related]
16. Effect of Omega-3 fatty acid supplementation on markers of platelet and endothelial function in patients with peripheral arterial disease.
Mackay I; Ford I; Thies F; Fielding S; Bachoo P; Brittenden J
Atherosclerosis; 2012 Apr; 221(2):514-20. PubMed ID: 22296885
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
18. A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trial.
Hudson R; Pascoe EM; See YP; Cho Y; Polkinghorne KR; Paul-Brent PA; Hooi LS; Ong LM; Mori TA; Badve SV; Cass A; Kerr PG; Voss D; Hawley CM; Johnson DW; Irish AB; Viecelli AK
J Vasc Access; 2024 Jan; 25(1):193-202. PubMed ID: 35686506
[TBL] [Abstract][Full Text] [Related]
19. Primary thromboprophylaxis with heparins for arteriovenous fistula failure in pediatric patients.
Sharathkumar A; Hirschl R; Pipe S; Crandell C; Adams B; Lin JJ
J Vasc Access; 2007; 8(4):235-44. PubMed ID: 18161668
[TBL] [Abstract][Full Text] [Related]
20. Anaesthesia Choice for Creation of Arteriovenous Fistula (ACCess) study protocol : a randomised controlled trial comparing primary unassisted patency at 1 year of primary arteriovenous fistulae created under regional compared to local anaesthesia.
Macfarlane AJ; Kearns RJ; Clancy MJ; Kingsmore D; Stevenson K; Jackson A; Mark P; Aitken M; Moonesinghe R; Vindrola-Padros C; Gaianu L; Pettigrew G; Motallebzadeh R; Karydis N; Vesey A; Singh R; Muniraju T; Suttie S; McConnachie A; Wetherall K; El-Boghdadly K; Hogg R; Thomson I; Nangalia V; Aitken E; ;
BMJ Open; 2021 Dec; 11(12):e052188. PubMed ID: 34937718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
